Home » Newsletters » BioWorld

BioWorld

Nov. 9, 1999

View Archived Issues

Phase III Data Of Amgen's NESP Appears To Support NDA Filing

Biotech In Eastern Europe Still Has Catching Up To Do

Harvard-Penn Team Achieves Immune Tolerance Of Donor Grafts By Foiling T-Cell Attack

ReoPro Alone, In Combination Continues To Show Promise

Other News To Note

European Patent Disclosures